Teladoc Health TDOC Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 69.3%-1.2pp | 69.5%-1.3pp | 69.8%-1.0pp | 70.3%-0.5pp | 70.5%-0.3pp | |
| Operating margin | -8.1%+33.2pp | -10.4%+29.3pp | -10.9%+28.0pp | -10.5%+28.9pp | -41.3%-31.4pp | |
| Net margin | -6.8%+32.9pp | -7.9%+31.0pp | -8.8%+29.1pp | -8.2%+30.4pp | -39.7%-30.8pp | |
| EBITDA margin | 6.1%+33.5pp | 3.5%+29.1pp | 2.8%+27.3pp | 3.1%+28.0pp | -27.5%-31.3pp | |
| Free cash flow margin | 11.1%-0.2pp | 11.3%+0.3pp | 11.1%-1.7pp | 11.5%-0.9pp | 11.3%-1.5pp | |
| Returns | ||||||
| Return on equity | -12.4%+42.1pp | -13.9%+38.5pp | -15.4%+36.2pp | -14.2%+38.8pp | -54.5%-44.3pp | |
| Return on assets | -5.5%+20.6pp | -6.3%+19.0pp | -7%+18.0pp | -6.5%+19.2pp | -26.1%-20.7pp | |
| Return on invested capital | -28%+73.8pp | -36.6%+63.4pp | -34.9%+57.9pp | -31.1%+57.4pp | -101.9%-82.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.8×+0.1× | 0.8×+0.1× | 0.8×+0.1× | 0.8×+0.1× | 0.7×+0.1× | |
| Inventory turnover | 22.2×+0.8× | 20.2×-2.0× | 19.9×-0.9× | 20.7×-1.4× | 21.4×+1.9× | |
| Liquidity | ||||||
| Current ratio | 2.8×+1.1× | 2.8×+1.0× | 2.7×+1.0× | 2.7×+1.0× | 1.7×-2.1× | |
| Quick ratio | 2.7×+1.1× | 2.7×+0.9× | 2.6×+0.9× | 2.6×+1.0× | 1.6×-2.1× | |
| Cash ratio | 1.9×+0.6× | 1.9×+0.6× | 1.8×+0.5× | 1.7×+0.4× | 1.3×-1.6× | |
| Leverage | ||||||
| Debt-to-equity | 0×-0.4× | 0×-0.4× | 0×-0.4× | 0×-0.4× | 0.4×+0.4× | |
| Debt-to-assets | 0×-0.2× | 0×-0.2× | 0×-0.2× | 0×-0.2× | 0.2×+0.2× | |
| Net debt / EBITDA | -4.7×— | -8.4×— | -9.7×— | -8.1×— | —— | |
| Interest coverage | -10.6×+33.5× | -13.3×+29.6× | -12.7×+32.1× | -11.8×+34.0× | -44.1×-32.7× | |
| Per Share | ||||||
| Book value per share | $7.46-9.0% | $7.86-10.1% | $7.87-10.5% | $8.08-8.4% | $8.19-40.0% | |
| Valuation | ||||||
| Market capitalization | $1.41B+16.5% | $1.24B-20.6% | $1.37B-12.6% | $1.4B-14.4% | $1.38B-45.4% | |
| Enterprise value | $701.31M+14.7% | $506.47M-41.1% | $687.6M-25.0% | $765.78M-28.9% | $783.58M-47.3% | |
| Price / sales | 0.6×+0.1× | 0.5×-0.1× | 0.5×-0.1× | 0.6×-0.1× | 0.5×-0.4× | |
| Price / book | 1.1×+0.2× | 0.9×-0.2× | 1×-0.1× | 1×-0.1× | 1×-0.1× | |
| EV / EBITDA | 4.6×— | 5.8×— | 9.8×— | 9.7×— | —— | |
| EV / sales | 0.3×0.0× | 0.2×-0.1× | 0.3×-0.1× | 0.3×-0.1× | 0.3×-0.3× | |
| Free cash flow yield | 19.9%-3.9pp | 23%+4.9pp | 20.5%-0.7pp | 20.8%+1.1pp | 20.9%+7.6pp | |
| Earnings yield | -12.1%+71.5pp | -16.1%+47.9pp | -16.4%+46.5pp | -14.8%+46.5pp | -73.2%-64.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Teladoc Health's profit margins?
- Teladoc Health (TDOC) runs a 69.3% gross margin and a -8.1% operating margin, with a -6.8% net margin.
- Where do Teladoc Health's ratios come from?
- Every ratio is computed from Teladoc Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
